Condition category
Not Applicable
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Background and study aims
This study will evaluate the impact of results based financing (RBF) on priority maternal (mother) and child health services in rural districts of Zimbabwe. RBF is an output based financing mechanism where the health providers receive financial incentives to provide a pre-agreed set of services designed to help people in poor countries to live healthier lives. The objective of the Zimbabwe RBF impact evaluation is to inform policy regarding the effectiveness of the RBF model and support the government with additional evidence for potential scale up. The primary research question is – “What is the causal effect of results based financing with suspension of user fees on priority population health utilization and outcome measures in intervention districts?”

Who can participate?
Participating health facilities come from the selected 16 rural districts for implementation of RBF.

What does the study involve?
The government has selected 16 districts to implement RBF with two in each rural province of the country. All health facilities in these 16 districts will receive RBF incentives every 3 months based on a set of indicators related to maternal and child health. The facilities receive incentives on quantity (volume of services), quality (adherence to national standards of care), and client satisfaction. All participating health facilities receive RBF resources according to their level of service provision (primary, secondary or hybrid, i.e. primary plus secondary) and remoteness. The comparison districts have been selected within each province with pair-matching on geographical accessibility (i.e. rural and remoteness), type and level of health facilities, average facility catchment population, proportion of staff in position, presence of key staff such as the District Medical Officer, health services utilization rates such as antenatal care coverage, postnatal care coverage, institutional delivery and immunization
rates. The facilities in comparison districts will not receive any RBF incentives (business-as-usual).

What are the possible benefits and risks of participating?
The health facilities will benefit from the financial resources tied with performance. There are no side effects or risks of this intervention.

Where is the study run from?
There are 356 health facilities from 16 rural districts participating in this study. The implementing agency is the Ministry of Health and Child Care, Zimbabwe.

When is study starting and how long is it expected to run for?
March 2012 to March 2015.

Who is funding the study?
Governments of Norway and the UK through the Health Results Innovation Trust Fund administered by the World Bank

Who is the main contact?
Ashis Das

Trial website

Contact information



Primary contact

Dr Jed Friedman


Contact details

The World Bank
1818 H Street NW
United States of America

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

The effects of results based financing on maternal and child health access and utilization in rural Zimbabwe: Impact Evaluation of Zimbabwe’s Health Results Based Financing Project


Zimbabwe RBF IE

Study hypothesis

Results based financing increases access to and utilization of maternal and child health services in rural Zimbabwe

Ethics approval

Medical Research Council of Zimbabwe, 29/11/2011, ref. MRCZ/A/1648

Study design

Controlled before and after study; quasi-experimental study

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type

Quality of life

Patient information sheet


Maternal and child health


Health facilities within RBF districts will receive incentives every quarter based on attaining
1. Quantity (volume of services)
2. Quality (adherence to national standards of care)
3. Client satisfaction
Health facilities in the control districts receive no incentives (business-as-usual).

Intervention type



Drug names

Primary outcome measure

Health utilization indicators:
1. Antenatal care
2. Institutional delivery
3. Postnatal care
4. Immunization
5. Outpatient consultations
6. Referral
7. Adoption of family planning methods
8. ARV prophylaxis
Household level indicators:
1. Household health seeking behavior
2. Out-of-pocket healthcare expenditure
3. Satisfaction on the service provider
These will be measured through a household survey at the end of the intervention

Secondary outcome measures

Health facility infrastructure indicators:
1. Drug stockout rates
2. Availability of drugs
3. Availability of clinical protocols
4. Availability of equipment
5. Updated records
Quality of care indicators:
1. Counseling and client interaction
2. Waiting time
3. Physical examination
Equity indicators:
1. Utilization of health care and quality of care indicators vis-à-vis clients' socio-economic and residence status
Health worker indicators:
1. Health worker training status
2. Knowledge
3. Motivation
4. Job satisfaction
These will be measured through a health facility survey at the end of the intervention

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Health facilities within the selected 16 rural districts and matched control districts
2. Health facilities contracted under RBF project

Participant type


Age group




Target number of participants

All health facilities in participating rural districts (n=356)

Participant exclusion criteria

1. Health facilities outside the selected 32 rural districts
2. Health facilities not contracted under RBF project

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

The World Bank
Washington, D.C.
United States of America

Sponsor information


Health Results Innovation Trust Fund, World Bank (USA)

Sponsor details

The World Bank
1818 H St NW
United States of America

Sponsor type




Funder type


Funder name

Health Results Innovation Trust Fund, World Bank (USA)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

2017 thesis in (added 25/06/2020)

Intention to publish date

Participant level data

Not provided at time of registration

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

25/06/2020: Link to thesis added to publication and dissemination plan.